Cargando…

Linezolid for drug‐resistant pulmonary tuberculosis

BACKGROUND: Linezolid was recently re‐classified as a Group A drug by the World Health Organization (WHO) for treatment of multi‐drug resistant tuberculosis (MDR‐TB) and extensively drug‐resistant tuberculosis (XDR‐TB), suggesting that it should be included in the regimen for all patients unless con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Bhagteshwar, Cocker, Derek, Ryan, Hannah, Sloan, Derek J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2019
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426281/ https://www.ncbi.nlm.nih.gov/pubmed/30893466 http://dx.doi.org/10.1002/14651858.CD012836.pub2

Ejemplares similares

Linezolid Pharmacokinetics and Its Association with Adverse Drug Reactions in Patients with Drug-Resistant Pulmonary Tuberculosis
por: Padmapriyadarsini, Chandrasekaran, et al.
Publicado: (2023)

Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman
por: Jaspard, Marie, et al.
Publicado: (2017)

The role of delamanid in the treatment of drug-resistant tuberculosis
por: Lewis, Joseph M, et al.
Publicado: (2015)

Bedaquiline, pretomanid and linezolid for treatment of extensively drug resistant, intolerant or non-responsive multidrug resistant pulmonary tuberculosis
por: Conradie, Francesca, et al.
Publicado: (2020)

Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis
por: Mockeliunas, Laurynas, et al.
Publicado: (2022)

Low Rate of Acquired Linezolid Resistance in Multidrug-Resistant Tuberculosis Treated With Bedaquiline-Linezolid Combination
por: Du, Jian, et al.
Publicado: (2021)

Linezolid-resistant Mycobacterium tuberculosis: Will it impact the tuberculosis elimination programme?
por: Bharadwaj, Renu
Publicado: (2021)

Linezolid-Associated Optic Neuropathy in Drug-Resistant Tuberculosis Patients in Mumbai, India
por: Mehta, Salil, et al.
Publicado: (2016)

Bedaquiline, Delamanid, Linezolid, and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis
por: Padmapriyadarsini, Chandrasekaran, et al.
Publicado: (2022)

Linezolid resistance in patients with drug-resistant TB
por: Vengurlekar, D., et al.
Publicado: (2023)

Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis
por: Diacon, Andreas H., et al.
Publicado: (2020)

Changes in chest CT findings of pulmonary tuberculosis after linezolid treatment
por: Kim, Sanghyeon, et al.
Publicado: (2013)

Low-Dose Linezolid for Treatment of Patients With Multidrug-Resistant Tuberculosis
por: Mase, Anjeli, et al.
Publicado: (2022)

Proposed Linezolid Dosing Strategies to Minimize Adverse Events for Treatment of Extensively Drug-Resistant Tuberculosis
por: Imperial, Marjorie Z, et al.
Publicado: (2021)

Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
por: Oehadian, Amaylia, et al.
Publicado: (2022)

Linezolid Resistance in Staphylococci
por: Stefani, Stefania, et al.
Publicado: (2010)

Effect of linezolid on serum PCT, ESR, and CRP in patients with pulmonary tuberculosis and pneumonia
por: Ding, Rui-Dong, et al.
Publicado: (2018)

Linezolid-resistant enterococci in Polish hospitals: species, clonality and determinants of linezolid resistance
por: Gawryszewska, I., et al.
Publicado: (2017)

Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment
por: Keutzer, Lina, et al.
Publicado: (2023)

Mechanism underlying linezolid-induced peripheral neuropathy in multidrug-resistant tuberculosis
por: Yuan, Yuan, et al.
Publicado: (2022)

Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis
por: Zhang, Haoyue, et al.
Publicado: (2023)

Linezolid resistance in multidrug-resistant mycobacterium tuberculosis: A systematic review and meta-analysis
por: Azimi, Taher, et al.
Publicado: (2022)

Clinical Outcomes Associated With Linezolid Resistance in Leukemia Patients With Linezolid-Resistant Staphylococcus epidermidis Bacteremia
por: Folan, Stephanie A, et al.
Publicado: (2018)

Genetic and Virulence Characteristics of Linezolid and Pretomanid Dual Drug-Resistant Strains Induced from Mycobacterium tuberculosis in vitro
por: Hu, Minghao, et al.
Publicado: (2020)

Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines
por: Gomez, Gabriela Beatriz, et al.
Publicado: (2021)

The occurrence and frequency of genomic mutations that mediate Isoniazid and Rifampicin resistance in Mycobacterium tuberculosis isolates from untreated pulmonary Tuberculosis cases in urban Blantyre, Malawi
por: Kumwenda, Geoffrey P, et al.
Publicado: (2018)

Linezolid in the Starter Combination for Multidrug-Resistant Tuberculosis: Time to Move on to Group Four?
por: Grard, Soazic, et al.
Publicado: (2015)

Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France
por: Jaspard, Marie, et al.
Publicado: (2020)

Genetic Profile of Linezolid-Resistant M. tuberculosis Clinical Strains from Moscow
por: Ushtanit, Anastasia, et al.
Publicado: (2021)

Mechanisms of Linezolid Resistance in Mycobacteria
por: Gan, Wei Chong, et al.
Publicado: (2023)

Therapeutic drug monitoring: linezolid too?
por: Richards, Guy A, et al.
Publicado: (2014)

The Synergistic Activity of Rhamnolipid Combined with Linezolid against Linezolid-Resistant Enterococcus faecium
por: Chang, Qingru, et al.
Publicado: (2023)

Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps
por: Deshpande, Devyani, et al.
Publicado: (2016)

Linezolid resistance in patients with drug-resistant TB and treatment failure in South Africa
por: Wasserman, Sean, et al.
Publicado: (2019)

Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis
por: Song, Taeksun, et al.
Publicado: (2015)

Reversible recurrent profound thrombocytopenia due to linezolid in a patient with multi-drug resistant tuberculosis: A case report
por: Wang, Ming-Gui, et al.
Publicado: (2018)

Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea
por: Yang, Jeong Seong, et al.
Publicado: (2018)

Linezolid for Treating Tuberculosis: A Delicate Balancing Act
por: Maartens, Gary, et al.
Publicado: (2015)

Synergy of Linezolid with Several Antimicrobial Agents against Linezolid-Methicillin-Resistant Staphylococcal Strains
por: Valderrama, María-José, et al.
Publicado: (2020)

Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis
por: Srivastava, Shashikant, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jlgqinruoc33jra53o2ch0qk2i